SG
INBS icon

StoneX Group’s Intelligent Bio Solutions INBS Stock Holding History

StoneX Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$2.63K – 572
2022
Q4 		$2.63K Buy
+5
New +$4.79K ﹤0.01% 524

Other funds holding INBS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

StoneX Group's INBS Position: Q1 2023 in Review

StoneX Group sold out of Intelligent Bio Solutions (INBS) in Q1 2023, closing a stake of 5 shares — an estimated $2.63K sold.

StoneX Group first reported a position in INBS in Q4 2022 and held it in 1 quarter. The position peaked at $2.63K in Q4 2022. 4 funds tracked by Wall St. Rank hold INBS as of Q1 2023.

  • StoneX Group reported no remaining Intelligent Bio Solutions position as of Q1 2023 after selling out during the quarter.
  • StoneX Group sold 5 Intelligent Bio Solutions shares in Q1 2023, an estimated $2.63K.
  • StoneX Group first reported a position in Intelligent Bio Solutions in Q4 2022 and held it in 1 quarter.
  • StoneX Group's Intelligent Bio Solutions position peaked at $2.63K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.